Eisai

Patients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LEC

Ondansetron

Phase 2

Postoperative Nausea and Vomiting

pemetrexed

Phase 2

Non Small Cell Lung Cancer

H3B-6545

Phase 2

Breast Neoplasms

E7386

Phase 2

Melanoma

Avatrombopag tablets

Phase 2

Chronic Idiopathic Thrombocytopenic Purpura

Donepezil HCl

Phase 2

Down Syndrome

AQUAVAN (fospropofol disodium; GPI 15715 )

Phase 2

Postoperative Sedation

Lemborexant 2.5 mg

Phase 2

Irregular Sleep-Wake Rhythm Disorder

E5564

Phase 2

Sepsis

Irsenontrine

Phase 2

Dementia With Lewy Bodies

E5555

Phase 2

Coronary Artery Disease

fospropofol

Phase 2

Ischemic Coronary Artery Disease

E6201 0.005%

Phase 2

Chronic Plaque Psoriasis

Rabeprazole 20 mg

Phase 2

Gastroesophageal Reflux Disease

E7389 28 Day Cycle

Phase 2

Non-Small-Cell Lung Carcinoma

Perampanel Oral Suspension

Phase 2

Pediatric Epileptic Syndrome

Pegylated interferon (PEG-IFN)

Phase 2

Thrombocytopenia

E7389-LF

Phase 2

Solid Neoplasms

MORAb-004 (monoclonal antibody)

Phase 2

Metastatic Melanoma

BSC

Phase 2

Non-Small Cell Lung Cancer

Open Label (Avatrombopag tablets)

Phase 2

Idiopathic Thrombocytopenic Purpura

Cyclophosphamide

Phase 2

Lymphoma, T-Cell, Peripheral

E2027

Phase 2

Lewy Body Disease

0.03% E6201

Phase 2

Psoriasis Vulgaris

Doxorubicin

Phase 2

Endometrial Neoplasms

Drug Name	Phase	Indication	Designations	Patent
Avatrombopag	Phase 3	Chronic Thrombocytopenia	-	-
Lenvatinib	Phase 3	Hepatocellular Carcinoma	-	-
E2007	Phase 3	Refractory Partial Seizures	-	-
E7777 9 mcg/kg	Phase 3	Persistent or Recurrent Cutaneous T-Cell Lymphoma	-	-
Eszopiclone 1 mg- Elderly	Phase 3	Insomnia	-	-
E7389 (Eribulin Mesylate)	Phase 3	HER2-Negative Breast Cancer	-	-
Cinitapride	Phase 3	Dyspepsia	-	-
Amolimogene	Phase 3	Uterine Cervical Dysplasia	-	-
E7337	Phase 3	Lesions of the Liver	-	-
everolimus	Phase 3	Renal Cell Carcinoma	-	-
Eperisone	Phase 3	Muscle Spasm; Back Pain	-	-
Pembrolizumab	Phase 3	Endometrial Neoplasms	-	-
menatetranone	Phase 3	Postmenopausal Osteoporosis	-	-
Rabeprazole	Phase 3	Gastric Ulcers Duodenal Ulcers Caused by Low-dose Aspirin	-	-
2 mg perampanel	Phase 3	Parkinson's Disease	-	-
bexarotene with carboplatin and paclitaxel	Phase 3	Non-small Cell Lung Cancer	-	-
Esomeprazole	Phase 3	Gastroesophageal Reflux Disease (GERD)	-	-
T-614	Phase 3	Rheumatoid Arthritis	-	-
Dotinurad	Phase 3	Gout	-	-
Rabeprazole sodium	Phase 3	Gastroesophageal Reflux Disease (GERD)	-	-
E0302 (mecobalamin)	Phase 3	Amyotrophic Lateral Sclerosis (ALS)	-	-
Donepezil 5 mg	Phase 3	Dementia With Lewy Bodies (DLB)	-	-
Physician's Choice	Phase 3	Breast Cancer	-	-
Aricept (donepezil SR 23 mg)	Phase 3	Alzheimer's Disease	-	-
lemborexant	Phase 3	Insomnia Disorder	-	-
Perampanel	Phase 3	Epilepsy	-	-
Midazolam HCI	Phase 3	Conscious Sedation	-	-
Zolpidem tartrate	Phase 3	Insomnia	-	-
Donepezil hydrochloride	Phase 3	Attention Impairment	-	-
Eszopiclone 1 mg	Phase 3	Primary Insomnia	-	-
Ranitidine	Phase 3	Gastroesophageal Reflux Disease (GERD)	-	-
Lorcaserin 10 mg twice a day (BID)	Phase 3	Obesity	-	-
Rabeprazole ER	Phase 3	Gastroesophageal Reflux Disease (GERD)	-	-
E2007 (perampanel)	Phase 3	Refractory Partial Seizures	-	-
Sibutramine Hydrochloride Monohydrate	Phase 3	Obesity	-	-
fospropofol disodium	Phase 3	Colonoscopy	-	-
methylcobalamin	Phase 3	Amyotrophic Lateral Sclerosis	-	-
Sunitinib	Phase 3	Renal Cell Carcinoma	-	-
E3810	Phase 3	Non-erosive Gastroesophageal Reflux Disease	-	-
Lamotrigine	Phase 3	Epilepsy	-	-
Teprenone	Phase 3	Gastric or Duodenal Ulcers Caused by Low-dose Aspirin	-	-
Zonisamide	Phase 3	Epilepsy; Paediatric Partial Onset Seizures	-	-
Lorcaserin 10 mg once daily (QD)	Phase 3	Obesity	-	-
Rufinamide	Phase 3	Lennox-Gastaut Syndrome	-	-
Lecanemab	Phase 3	Preclinical Alzheimer's Disease	-	-
Donepezil	Phase 3	Alzheimer's Disease	-	-
avatrombopag (lower baseline platelet count)	Phase 3	Thrombocytopenia Associated With Liver Disease	-	-
E7389	Phase 3	Breast Cancer	-	-
Carbamazepine	Phase 3	Epilepsy	-	-
bexarotene	Phase 3	Non-small Cell Lung Cancer	-	-
LEM 5 mg	Phase 3	Insomnia	-	-
E2007 (2 mg)	Phase 3	Diabetic Neuropathy	-	-
E2020	Phase 3	Alzheimer's Type Dementia	-	-
Eribulin	Phase 3	Non-Small Cell Lung Cancer (NSCLC)	-	-
Midazolam HCl	Phase 3	Colonoscopy	-	-
Lorcaserin 10 mg BID	Phase 3	Obesity	-	-
avatrombopag (higher baseline platelet count)	Phase 3	Thrombocytopenia Associated With Liver Disease	-	-
Cytarabine or Supportive Care	Phase 3	Acute Myeloid Leukemia	-	-
Eperisone hydrochloride and Diclofenac sodium	Phase 3	Acute Musculoskeletal Spasm Due to Low Back Pain	-	-
Rufinamide (E2080)	Phase 3	Lennox-Gastaut Syndrome	-	-
fluorouracil	Phase 3	Pancreatic Cancer	-	-
Irofulven	Phase 3	Prostate Cancer	-	-
AQUAVAN® (fospropofol disodium) Injection	Phase 3	Bronchoscopy	-	-
Aricept	Phase 3	Cognitive Impairment	-	-
Eribulin Mesylate	Phase 3	Breast Cancer	-	-
Capecitabine	Phase 3	Metastatic Breast Cancer	-	-
Clevudine	Phase 3	Chronic Hepatitis B	-	-
Prior Donepezil 5mg	Phase 3	Parkinson's Disease	-	-
Ranirestat	Phase 3	Mild to Moderate Diabetic Sensorimotor Polyneuropathy	-	-
eritoran tetrasodium	Phase 3	Severe Sepsis	-	-
Eribulin mesylate 1.4 mg/m^2 intravenous	Phase 3	Soft Tissue Sarcoma	-	-
Sorafenib	Phase 3	Hepatocellular Carcinoma (HCC)	-	-
Ixabepilone	Phase 2	Breast Cancer	-	-
E7080 capsule	Phase 2	Thyroid Cancer	-	-
BOTULINUM TOXIN TYPE B	Phase 2	Cervical Dystonia	-	-
E2020-Donepezil hydrochloride	Phase 2	Down Syndrome	-	-
E7777	Phase 2	Peripheral T-cell Lymphoma	-	-
Rabeprazole sodium, 5 mg Tablets	Phase 2	Healthy	-	-
E7090	Phase 2	Cholangiocarcinoma	-	-
E5555 50 mg	Phase 2	Coronary Artery Disease	-	-
Tazemetostat	Phase 2	Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma	-	-
3 mg Donepezil hydrochloride	Phase 2	Dementia With Lewy Bodies (DLB)	-	-
E6742	Phase 2	Lupus Erythematosus, Systemic	-	-
E7050	Phase 2	Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck	-	-
E2014 (Botulinum toxin type B)	Phase 2	Spasmodic Torticollis	-	-
eribulin mesylate + erlotinib	Phase 2	Non-small Cell Lung Cancer	-	-
Farletuzumab	Phase 2	Platinum-Sensitive Ovarian Cancer in First Relapse	-	-
Irofulven + capecitabine	Phase 2	Thyroid Cancer	-	-
BB-1701	Phase 2	Breast Cancer	-	-
E7449 alone	Phase 2	Malignant Solid Tumour	-	-
APD356	Phase 2	Obesity	-	-
ONTAK (denileukin diftitox)	Phase 2	Lymphoma, B-Cell	-	-
Iomeprole	Phase 2	Lesion	-	-
Eribulin mesilate	Phase 2	Refractory or Recurrent Solid Tumors	-	-
E7070	Phase 2	Kidney Neoplasms	-	-
Aricept (donepezil hydrochloride)	Phase 2	Migraine Headache	-	-
Lenvatinib (DTC Cohort)	Phase 2	Thyroid Cancer	-	-
Oxaliplatin	Phase 2	Liver Cancer	-	-
Palonosetron	Phase 2	Multiple Myeloma	-	-
Etoposide	Phase 2	Tumors	-	-
Dacarbazine	Phase 2	Stage IV Melanoma	-	-
E7080	Phase 2	Solid Tumors	-	-
ONTAK	Phase 2	Non-Hodgkin's Lymphoma	-	-
E6011	Phase 2	Rheumatoid Arthritis	-	-
E2814	Phase 2	Alzheimer Disease	-	-
GPI 1485	Phase 2	Parkinson's Disease	-	-
Ifosfamide	Phase 2	Osteosarcoma	-	-
Denileukin diftitox	Phase 2	Stage IIIC Melanoma	-	-
Farletuzumab ecteribulin	Phase 2	Solid Tumor	-	-
E2006	Phase 2	Chronic Insomnia	-	-
E7820 plus cetuximab	Phase 2	Advanced Colorectal Cancer	-	-
Lecanemab 2.5 mg/kg	Phase 2	Alzheimer's Disease	-	-
GLIADEL	Phase 2	Metastatic Brain Cancer	-	-
decitabine	Phase 2	Myelodysplastic Syndrome	-	-
palonesetron	Phase 2	Patients With Confirmed Malignant Disease to Receive Low Emetogenic Chemotherapy (LEC) or Who Experienced at Least Nausea and Vomiting During Last Cycle of LEC	-	-
Ondansetron	Phase 2	Postoperative Nausea and Vomiting	-	-
pemetrexed	Phase 2	Non Small Cell Lung Cancer	-	-
H3B-6545	Phase 2	Breast Neoplasms	-	-
E7386	Phase 2	Melanoma	-	-
Avatrombopag tablets	Phase 2	Chronic Idiopathic Thrombocytopenic Purpura	-	-
Donepezil HCl	Phase 2	Down Syndrome	-	-
AQUAVAN (fospropofol disodium; GPI 15715 )	Phase 2	Postoperative Sedation	-	-
Lemborexant 2.5 mg	Phase 2	Irregular Sleep-Wake Rhythm Disorder	-	-
E5564	Phase 2	Sepsis	-	-
Irsenontrine	Phase 2	Dementia With Lewy Bodies	-	-
E5555	Phase 2	Coronary Artery Disease	-	-
fospropofol	Phase 2	Ischemic Coronary Artery Disease	-	-
E6201 0.005%	Phase 2	Chronic Plaque Psoriasis	-	-
Rabeprazole 20 mg	Phase 2	Gastroesophageal Reflux Disease	-	-
E7389 28 Day Cycle	Phase 2	Non-Small-Cell Lung Carcinoma	-	-
Perampanel Oral Suspension	Phase 2	Pediatric Epileptic Syndrome	-	-
Pegylated interferon (PEG-IFN)	Phase 2	Thrombocytopenia	-	-
E7389-LF	Phase 2	Solid Neoplasms	-	-
MORAb-004 (monoclonal antibody)	Phase 2	Metastatic Melanoma	-	-
BSC	Phase 2	Non-Small Cell Lung Cancer	-	-
Open Label (Avatrombopag tablets)	Phase 2	Idiopathic Thrombocytopenic Purpura	-	-
Cyclophosphamide	Phase 2	Lymphoma, T-Cell, Peripheral	-	-
E2027	Phase 2	Lewy Body Disease	-	-
0.03% E6201	Phase 2	Psoriasis Vulgaris	-	-
Doxorubicin	Phase 2	Endometrial Neoplasms	-	-

Regulatory Approvals

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply

Eisai

Market Overview

ESALY News

Catalyst Timeline

Pipeline & FDA Submissions

AI Predictions & Institutional Flow

Market Intelligence

Regulatory Approvals